Effectiveness of Video-Based Movement Analysis-Guided Personalized Rehabilitation in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Inclusion Criteria:

* Adult patients aged 19 years or older.
* Diagnosed with breast cancer, colorectal cancer, or gynecological cancer, and currently receiving chemotherapy or under follow-up observation after completing treatment.
* History of treatment with neurotoxic chemotherapeutic agents (e.g., taxane, platinum, etc.) or experiencing related symptoms.
* Symptoms or risk of chemotherapy-induced peripheral neuropathy (CIPN) (NCI-CTCAE Grade \>= 1).
* Able to walk independently (with or without assistive devices).
* Able to understand the study purpose and procedures and voluntarily provide written informed consent.

Exclusion Criteria:

* Peripheral neuropathy clearly attributable to causes other than CIPN, such as diabetic neuropathy.
* Severe central nervous system disorders (e.g., stroke, Parkinson's disease, etc.) or severe musculoskeletal disorders that make functional assessment or exercise performance difficult.
* Severe cognitive impairment that interferes with study participation or the ability to follow instructions.
* Recent significant injury due to a fall, or cases where exercise performance is deemed medically unsafe.
* Recurrent or progressive cancer with an unstable general systemic condition.
* Any other condition or clinical reason that, in the opinion of the investigator, makes participation in the study inappropriate.